BriaCell develops ovarian cancer immunotherapy candidate

Go back to BriaCell develops ovarian cancer immunotherapy candidate
(NASDAQ: BCTX) Delayed: 2.77 +0.03 (1.09%)
Previous Close $2.74    52 Week High
Open $2.78    52 Week Low
Day High $2.89    P/E N/A 
Day Low $2.63    EPS
Volume 192,404